Steve Harmon’s scientific contributions

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (2)


Generation of an AAH2-deficient strain and genetic complementation. (A) Schematic of AAH2 knockout strategy. (Left) HXGPRT construct flanked by 5′ and 3′ regions from the AAH2 genomic locus was used to knock out the AAH2 gene in the PruΔku80Δhxg background by double homologous crossover. MPA, mycophenolic acid; Xa, xanthine, which was used for selection. (Center) The deletion strain (Δaah2::HXG) was transfected with cleanup construct to remove the HXGPRT drug marker. (Right) The deletion strain (Δaah2::HXG) was complemented by replacing HXGPRT with a cDNA copy of AAH2. (B) Diagnostic PCR of the wild-type (PruΔku80Δhxg), deletion mutant (PruΔku80ΔhxgΔaah2), and complement (PruΔku80ΔhxgΔaah2::AAH2) lines. Arrows show the respective primers used to confirm the genetic architecture (see Table S1 in the supplemental material). Expected product sizes were the following: AAH1, 4.820 kb; AAH2, 4.820 kb; AAH2 cDNA, 1.698 kb. (C) Plaque assay measuring in vitro growth of strains on HFF monolayers stained with crystal violet.
Differentiation into bradyzoites in vitro. (A) Formation of cysts by wild-type, Δaah2, and Δaah2::AAH2 parasites in tachyzoite and bradyzoite conditions in vitro. Partial and fully formed cysts were enumerated based on staining with DBL. There was no significant difference in cyst formation in bradyzoite-induced parasites (P = 1.00) and no significant difference in cyst formation (P = 0.66) or partial cyst formation (P = 0.88) in tachyzoite conditions (both determined by one-way ANOVA; n = 3 experiments). (B) Representative pictures of intact, partial, and absent cyst formation in parasite vacuoles. Blue, 4′,6-diamidino-2-phenylindole (DAPI); red, GRA7; green, DBL. Scale bar, 10 μm.
Differentiation and expression levels in tachyzoites and bradyzoites. (A) Quantitative real-time PCR comparing gene expression of bradyzoites relative to that of tachyzoites of wild-type, knockout (Δaah2), and complemented (Δaah2::AAH2) parasites. Stage-specific markers SAG1, BAG1, SAG2A, and LDH2, along with AAH1 and AAH2, were monitored with gene-specific primers (see Table S1 in the supplemental material). Results are means ± standard deviations (SD) (n = 3 experiments). Excluding the expected differences in AAH2 expression, expression differences between the genes probed were not significant (P = 0.19 by two-way ANOVA). (B) Western blot of bradyzoites expressing a Ty epitope-tagged AAH1 or AAH2 or a tagged copy of AAH2 driven by the BAG1 promoter. Red, GRA2; green, Ty. Expected protein sizes: AAH1 and AAH2, 55 kDa; GRA2 (dense granule protein 2), 28 kDa. (C) Immunofluorescent assay of AAH1-Ty-, AAH2-Ty-, and BAG1::H2Ty-tagged parasites differentiated into bradyzoites. Blue, DAPI; green, DBL; red, Ty. Scale bar, 10 μm.
Production of dopamine in infected PC12 cells. (A) Comparison of infection with wild-type, knockout (Δaah2), complement (Δaah2::AAH2), or BAG1-2Ty overexpressor tachyzoites in PC12 cells (P = 0.40 by one-way ANOVA). Results are means ± SD (n = 2 to 5 replicates). The y axis shows the ratio of dopamine content per PC12 cell relative to uninfected PC12s. (B) Comparison of dopamine content in PC12 cells grown under bradyzoite conditions (P = 0.4239 by one-way ANOVA). Results are means ± SD (n = 2 to 4).
Dopamine content in the brain of control and infected mice. (A) Parasite cyst burden in whole brains of CD1 mice examined at 1 (1 mo) or 2 months (2 mo) postinfection. Infection with ME49 at 1 mo showed significantly higher cyst burden (P = 0.0003 by Kruskal-Wallis test with Dunn's multiple comparisons for Pru strains and ME49). Infection with the type III C56 strain showed significantly lower cyst burden (P = 0.0003 by Kruskal-Wallis test with Dunn's multiple comparisons for Pru strains and C56), with 5 of 10 mice showing cyst burdens below the detectable limit of 20 cysts/brain (not plotted). (B) Dopamine levels in total brain homogenates in uninfected and infected mice at 1 (1mo) or 2 (2mo) months postinfection. Dopamine levels were not significantly different between infected or uninfected animals or between infection strains (P = 0.075 by Kruskal-Wallis test with Dunn's multiple comparisons test). (C) Linear regression analysis between cyst density and brain dopamine concentration in mice infected with ME49 for 1 month (1mo) or 2 months (2mo). R² = 0.1333 (red). If the highest point in the linear regression was removed, R² = 0.1175 (blue).
Reassessment of the Role of Aromatic Amino Acid Hydroxylases and the Effect of Infection by Toxoplasma gondii on Host Dopamine
  • Article
  • Full-text available

February 2015

·

32 Reads

·

70 Citations

Zi T. Wang

·

Steve Harmon

·

Karen L. O'Malley

·

Toxoplasma gondii infection has previously been described to cause infected mice to lose their fear of cat urine. This behavioral manipulation has been proposed to involve alterations of host dopamine pathways due to parasite-encoded aromatic amino acid hydroxylases. Here, we report successful knockout and complementation of the aromatic amino acid hydroxylase AAH2 gene, with no observable phenotype in parasite growth or differentiation in vitro and in vivo. Additionally, expression levels of the two aromatic amino acid hydroxylases were negligible both in tachyzoites and in bradyzoites. Finally, we were unable to confirm previously described effects of parasite infection on host dopamine either in vitro or in vivo, even when AAH2 was over-expressed using the BAG1 promoter. Together, these data indicate that AAH enzymes in the parasite do not cause global or regional alterations of dopamine in the host brain, although they may locally affect this pathway. Additionally, our findings suggest alternative roles for the AHH enzymes in T. gondii since AAH1 is essential for growth in non-dopaminergic cells. Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Download

The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons

May 2014

·

240 Reads

·

75 Citations

Molecular Neurodegeneration

·

Jeong Sook Kim-Han

·

Steve Harmon

·

[...]

·

Karen L O'Malley

6-hydroxydopamine (6-OHDA) is one of the most commonly used toxins for modeling degeneration of dopaminergic (DA) neurons in Parkinson's disease. 6-OHDA also causes axonal degeneration, a process that appears to precede the death of DA neurons. To understand the processes involved in 6-OHDA-mediated axonal degeneration, a microdevice designed to isolate axons fluidically from cell bodies was used in conjunction with green fluorescent protein (GFP)-labeled DA neurons. Results showed that 6-OHDA quickly induced mitochondrial transport dysfunction in both DA and non-DA axons. This appeared to be a general effect on transport function since 6-OHDA also disrupted transport of synaptophysin-tagged vesicles. The effects of 6-OHDA on mitochondrial transport were blocked by the addition of the SOD1-mimetic, Mn(III)tetrakis(4-benzoic acid)porphyrin chloride (MnTBAP), as well as the anti-oxidant N-acetyl-cysteine (NAC) suggesting that free radical species played a role in this process. Temporally, microtubule disruption and autophagy occurred after transport dysfunction yet before DA cell death following 6-OHDA treatment. The results from the study suggest that ROS-mediated transport dysfunction occurs early and plays a significant role in inducing axonal degeneration in response to 6-OHDA treatment.

Citations (2)


... It is interesting that the dopamine transporters Slc35f3 and Slc17a6 were 1.8-fold and 1.9-fold more abundant, respectively. Several research groups have previously seen a connection between T. gondii infection dopamine metabolism as well as host behavior (68)(69)(70)(71)(72). Perhaps, RNASeq at an earlier infection time point would capture greater differences in these dopamine transporters. ...

Reference:

Toxoplasmosis accelerates the progression of hereditary spastic paraplegia
Reassessment of the Role of Aromatic Amino Acid Hydroxylases and the Effect of Infection by Toxoplasma gondii on Host Dopamine

... This matches the retrograde degeneration mechanism, in which the axon degenerates before the cell body, eventually leading to neuronal loss (Tagliaferro and Burke, 2016). Since 6-OHDA was found to have a general degenerative effect on neurons by inducing axonal blockage and increasing expression of autophagy marker in both dopaminergic and non-dopaminergic neurons (Lu et al., 2014), it may lead to the degeneration of the GABAergic VTA-CA2 circuit in the disease model. Furthermore, the anatomical circuitry has been found to be the major route for pathological propagation (Henderson et al., 2019;Nouraei et al., 2018). ...

The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons

Molecular Neurodegeneration